Carcinoembryonic antigen (CEA) is highly expressed in patients with pancreatic cancer, gastric cancer and colorectal cancer, but its diagnostic specificity for pancreatic cancer is poor (18). Here, CEACAM5 is linked to pancreatic neoplasm.